Financials
Financial year 2025
BV Nefromedi from Lint, company number BE0736359662, closed financial year 2025 with a result of € 161,625 after tax. For that financial year BV Nefromedi recorded a gross margin of € 216,149 and equity of € 71,625. Compared with financial year 2024, the result moved from € 195,054 to € 161,625. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
€ 71,625
▲ € 61,625 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 161,625
▼ 17% vs 2024
Profit after tax over the fiscal year.
€ 45,761
▼ 70% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
62 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,844
▼ 69% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 126
▼ 21% vs 2024
Loans from banks and other lenders, long and short.
€ 101
▼ 99% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,963
▼ 2% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 222,641 | € 193,033 | € 213,334 | € 216,149 | ▲ 1% |
| Profit after taxes | € 176,248 | € 157,004 | € 195,054 | € 161,625 | ▼ 17% |
| Equity | € 723,292 | € 480,296 | € 10,000 | € 71,625 | ▲ € 61,625 |
| Total debts | € 38,208 | € 407,626 | € 388,700 | € 94,946 | ▼ 76% |
| Cash | € 540,556 | € 53,399 | € 151,980 | € 45,761 | ▼ 70% |
| Retained profit | € 713,292 | € 470,296 | € 0 | € 61,625 | |
| Dividend | € 0 | € 400,000 | € 665,350 | € 100,000 | ▼ 85% |
| Bank debt | € 0 | € 0 | € 160 | € 126 | ▼ 21% |
| Balance sheet total | € 761,500 | € 887,922 | € 398,700 | € 166,571 | ▼ 58% |
Key figures of BV Nefromedi, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BV Nefromedi?
What happened at BV Nefromedi in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 161,625 (▼ 17% vs 2024). Source: NBB ↗
- New establishment in Lint. KBO
- Start of the company according to the CBE. KBO
- Johan Scharpé became a director. NBB
In short
From € 176,248 profit in 2022 to € 161,625 profit in 2025.
Paid € 202,667 in corporate taxes since 2022.
Best year ever: 2024, with € 195,054 profit.
Paid out € 1.2 million in dividends to the owners in total.
Management
Behind BV Nefromedi is Johan Scharpé.
Directors
According to the 2025 annual accounts
Johan Scharpé
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Lindelei 17
2547 Lint
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0736.359.662
- VAT number
- BE 0736.359.662
- Registered office
- Lindelei 17, 2547 Lint
- Names & denominations
- BV Nefromedi
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 October 2019
- Peppol
- Active · Active since 24 Nov 2023